These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12629757)

  • 81. [Hyperuricemia].
    Hamada T; Hisatome I; Shigemasa C
    Nihon Naika Gakkai Zasshi; 2011 Feb; 100(2):406-12. PubMed ID: 21400878
    [No Abstract]   [Full Text] [Related]  

  • 82. Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: study using a rat model of hyperuricemia.
    Yamada H; Kotaki H; Furitsu H; Sawada Y; Iga T
    Biopharm Drug Dispos; 1999 Mar; 20(2):77-83. PubMed ID: 10206322
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Stopping progression in familial juvenile hyperuricemic nephropathy with benzbromarone?
    Lhotta K
    Kidney Int; 2003 Nov; 64(5):1920-1. PubMed ID: 14531831
    [No Abstract]   [Full Text] [Related]  

  • 84. Hypouricemia in the syndrome of inappropriate antidiuretic hormone.
    Belliveau RR
    N Engl J Med; 1980 Apr; 302(14):811. PubMed ID: 7354820
    [No Abstract]   [Full Text] [Related]  

  • 85. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone.
    Shichiri M; Shiigai T
    Nephron; 1986; 42(2):183-4. PubMed ID: 3945358
    [No Abstract]   [Full Text] [Related]  

  • 86. Hypouricemia.
    Kelley WN
    Arthritis Rheum; 1975; 18(6 Suppl):731-7. PubMed ID: 1239291
    [No Abstract]   [Full Text] [Related]  

  • 87. [Secondary hypouricemia in patients with malignant disease].
    Imamura S; Ueda T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():393-7. PubMed ID: 12629755
    [No Abstract]   [Full Text] [Related]  

  • 88. Fanconi syndrome with hypouricemia in an adult: family study.
    BEN-ISHAY D; DREYFUSS F; ULLMANN TD
    Am J Med; 1961 Nov; 31():793-800. PubMed ID: 13867012
    [No Abstract]   [Full Text] [Related]  

  • 89. [Chronic kidney disease].
    Ruedin P
    Rev Med Suisse; 2013 Jan; 9(371):232. PubMed ID: 23451576
    [No Abstract]   [Full Text] [Related]  

  • 90. Cholecystography and nephrotoxicity.
    Swales JD; Mudge GH
    N Engl J Med; 1971 Aug; 285(6):354. PubMed ID: 4997050
    [No Abstract]   [Full Text] [Related]  

  • 91. Prescribing for the patient with renal disease.
    Rolan P; Somogyi A
    Med J Aust; 1986 Sep; 145(5):210-5. PubMed ID: 2875383
    [No Abstract]   [Full Text] [Related]  

  • 92. A new uricosuric substance 5-[(1H-imidazol-1-yl)phenylmethyl]-2-methyl-1H-benzimidazole (C18H16N4).
    Gresser U; Zöllner N
    Klin Wochenschr; 1989 Jun; 67(12):645. PubMed ID: 2770180
    [No Abstract]   [Full Text] [Related]  

  • 93. Hyperuricemia and risk of hypertension resistant to therapy: a systematic review and meta-analysis: Erratum.
    J Hypertens; 2022 Sep; 40(9):1845. PubMed ID: 35943113
    [No Abstract]   [Full Text] [Related]  

  • 94. Radiocontrast agents and aspirin.
    Postlethwaite AE; Kelley WN
    JAMA; 1972 Mar; 219(11):1479. PubMed ID: 5066914
    [No Abstract]   [Full Text] [Related]  

  • 95. Is there anything good in uric acid?
    Hynes AM; Sayer JA
    QJM; 2012 Apr; 105(4):395. PubMed ID: 22267576
    [No Abstract]   [Full Text] [Related]  

  • 96. Hypouricemica and malignant disease.
    Nanji AA
    Can Med Assoc J; 1983 Feb; 128(3):250. PubMed ID: 6821782
    [No Abstract]   [Full Text] [Related]  

  • 97. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
    Hisatome I; Ogino K; Igawa O; Shigemasa C
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
    [No Abstract]   [Full Text] [Related]  

  • 98. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers.
    Berni A; Boddi M; Fattori EB; Cecioni I; Berardino S; Montuschi F; Chiostri M; Poggesi L
    Am J Hypertens; 2010 Jun; 23(6):675-80. PubMed ID: 20203626
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients.
    Kostka-Jeziorny K; Uruski P; Tykarski A
    Blood Press; 2011 Apr; 20(2):104-10. PubMed ID: 21405957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.